# CART-38 in Adult AML and MM Patients

> **NCT05442580** · PHASE1 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 11 (actual)

## Conditions studied

- Acute Myeloid Leukemia (AML)
- Multiple Myeloma (MM)

## Interventions

- **DRUG:** 3x10(6) CART-38 cellls
- **DRUG:** 7x10(5) CART-38 cells
- **DRUG:** 7x10(6) CART-38 cells
- **DRUG:** 3x10(7) CART-38 cells
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT05442580
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-05-30
- **Primary completion:** 2025-02-09
- **Final completion:** 2025-02-09
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Administrative decision
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05442580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05442580, "CART-38 in Adult AML and MM Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05442580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*